Jose A. Lasalde-Dominicci U.S. Patent No: Pending Caballero Rivera D, Biaggi-Labiosa NM, Avilez-Pagan E, Lasalde-Dominicci JA U.S. Patent No: 10,676,518 Valance-Washington A, Ferrer-Acosta Y, Morales J, Reyes-Baez F U.S. Patent No: 10,597,462 Lasalde-Dominicci; Jose A., Quesada-Gonzalez; Orestes, Rodriguez-Cordero, Josue, Baez-Pagan; Carlos U. S. Patent No: 10, 358, 475 Lasalde-Dominicci; José A., Quesada-González; Orestes, Rodríguez-Cordero, Josué, Báez-Pagan; Carlos U.S. Patent No: 10,155,221 Rivera JM, Negrón LM U.S. Patent No: 10,106,572 Rosenthal JJC, Montiel-González MF U.S. Patent No: 9,650,627PATENTS
USPTO
Pat NumTitle Inventors Date
1 10,155,221 High-throughput
crystallographic screening
device and method for
crystalizing membrane
proteins using a sub
physiological resting
membrane potential across
a lipid matrix of variable
composition.Lasalde-Dominicci;
Jose A., QuesadaGonzalez; Orestes,
Rodriguez-Cordero;
Josue, Baez-Pagan;
CarlosDecember
2018
2 10,106,572 Supramolecular hacky
sacks (SHS), method of
synthesis and applications
thereofRivera; Jose M,
Negron; Luis MOctober
2018
3 9,650,627 Site-directed RNA editing Rosenthal; Joshua J. C.,
Montiel-Gonzalez; Maria
FernandaMay 2017
4 10,676,518 A4B2 nicotinic
acetylcholine receptors
with reduced or increased
nicotine sensitivity and
transgenic mouse model
for the same.Caballero-Rivera; Daniel,
Biaggi-Labiosa; Nilza M,
Aviles-Pagan; Emir,
Lasalde-Dominicci; José
A.June 2020
5 10,358,475 High-throughput
crystallographic screening
device and method for
crystalizing membrane
proteins using a sub
physiological resting
membrane potential across
a lipid matrix of variable
compositionJose A. LasaldeDominicci, Orestes
Quesada-Gonzalez, Josue
Rodriguez-Cordero,
Carlos Baez-PaganJuly 2019
6 10,597,462 Anti-TLT-1 antibody and
uses thereofWashigton Anthony V March 2020
7 11,440,001 High-throughput
crystallographic screening
device and method for
crystalizing membrane
proteins using a sub
September 2022
8 physiological resting
membrane potential across
a lipid matrix of variable
composition
PUBLICATIONS
Publications up to October 2023 ” View pdf ” ⇒
Morales-Cruz M, Cruz-Montañez A, Figueroa CM, González-Robles T, Davila J, Inyushin M, Loza-Rosas SA, Molina AM, Muñoz-Perez L, Kucheryavykh LY, Tinoco AD, Griebenow K Martinez NA, Ayala AM, Martinez M, Martinez-Rivera FJ, Miranda JD, Silva WI Molina AM, Morales-Cruz M, Benítez M, Berríos K, Figueroa CM, Griebenow K Ramos FM, Delgado-Vélez M, Ortiz ÁL, Báez-Pagán CA, Quesada O, Lasalde-Dominicci JA Melendez RI, Roman C, Capo-Velez CM, Lasalde-Dominicci JA Delgado-Peraza F, Ahn KH, Nogueras-Ortiz C, Mungrue IN, Mackie K, Kendall DA, Yudowski GA Pézier AP, Jezzini SH, Bacon JP, Blagburn JM Negrón LM, Díaz TL, Ortiz-Quiles EO, Dieppa-Matos D, Madera-Soto B, Rivera JM Padilla-Morales LF, Colón-Sáez JO, González-Nieves JE, Quesada-González O, Lasalde-Dominicci JA Acevedo J, Santana-Almansa A, Matos-Vergara N, Marrero-Cordero LR, Cabezas-Bou E, Díaz-Ríos M Padilla-Morales LF, Colón-Sáez JO, González-Nieves JE, Quesada-González O, Lasalde-Dominicci JA Delgado-Vélez M, Báez-Pagán CA, Gerena Y, Quesada O, Santiago-Pérez LI, Capó-Vélez CM, Biaggi-Labiosa NM, Avilés-Pagán E, Caballero-Rivera D, Báez-Pagán CA, Lasalde-Dominicci JA Mosquera L, Shepherd L, Torrado AI, Torres-Diaz YM, Miranda JD, Segarra AC Oyola-Cintrón J, Caballero-Rivera D, Ballester L, Baéz-Pagán CA, Martínez HL, Vélez-Arroyo KP,
Mol. Pharm. 2016; 13 (8): 2844–2854. DOI: 10.1021/acs.molpharmaceut.6b00461
J. Biol. Chem. 2016; 291 (23): 12208–12222. DOI: 10.1074/jbc.M116.730226
J. Nanomedicine Nanotechnol. 2016; 6 (3): 1–8. DOI: 10.4172/2157-7439.1000294
J. Neurovirol. 2016; 22 (3): 327–335. DOI: 10.1007/s13365-015-0401-8
J. Neurovirol. 2016; 22 (3): 358–365. DOI: 10.1007/s13365-015-0403-6
Mol. Pharmacol. 2016; 89 (6): 618–629. DOI: 10.1124/mol.115.103176
PloS One. 2016; 11 (4): e0152211. DOI: 10.1371/journal.pone.0152211
Langmuir ACS J. Surf. Colloids. 2016; 32 (10): 2283–2290. DOI: 10.1021/acs.langmuir.5b03946
Data Brief. 2016; 6 (Supplement C): 433–437. DOI: 10.1016/j.dib.2015.12.010
Neuropharmacology. 2016; 101 (Supplement C): 490–505. DOI: 10.1016/j.neuropharm.2015.10.020
Biochim. Biophys. Acta. 2016; 1858 (1): 47–56. DOI: 10.1016/j.bbamem.2015.10.002
Wojna V, Meléndez L, León-Rivera R, Silva W, Lasalde-Dominicci JA
Clin. Transl. Immunol. 2015; 4 (12): e53. DOI: 10.1038/cti.2015.31
Neuropharmacology. 2015; 99 (Supplement C): 273–284. DOI: 10.1016/j.neuropharm.2015.04.022
J. Vet. Sci. Technol. 2015; 6 (6): 276. DOI: 10.4172/2157-7579.1000276
Quesada O, Lasalde-Dominicci JA
J. Biol. Chem. 2015; 290 (44): 26790–26800. DOI: 10.1074/jbc.M115.678573